Evonik Invests in Technical Upgrade of European Methionine Verbund
Evonik is investing a low double-digit million euros to upgrade its European methionine Verbund facilities in Antwerp, Belgium, and Wesseling, Germany. This investment aims to enhance process efficiency, reliability, and sustainability in the production of DL-methionine, a key amino acid used in animal feed. The technical upgrades will require a partial shutdown of the facilities for 8-10 weeks, scheduled between May and July 2025.
Key Investment in Process Improvement and Sustainability
The investment in Evonik’s European methionine Verbund is part of the company’s ongoing efforts to optimize its global production setup for MetAMINO® (DL-methionine). These technical upgrades will not only increase the efficiency and reliability of production but also contribute to the company’s sustainability goals.
According to Dr. Dirk Hoehler, Head of the Amino Acids Business at Evonik’s Animal Nutrition division, the company is committed to improving its global methionine production hubs. “We are constantly working to further increase the process efficiency, reliability, and sustainability of our three global methionine production hubs. This is how we remain competitive and ensure the highest possible supply security for our customers,” Hoehler said.
Partial Shutdown and Supply Security
The investment will require a partial shutdown of the Antwerp and Wesseling production facilities for approximately 8-10 weeks during the period from May to July 2025. Despite this temporary shutdown, Evonik has assured customers that all existing contracts and supply agreements will be fully honored.
This careful planning aims to minimize disruptions while ensuring that the upgrades are implemented smoothly and effectively. Evonik is determined to maintain its high levels of service to its customers and meet their needs during the upgrade period.
Process Efficiency and Technical Improvements
The technical upgrades at the Antwerp and Wesseling facilities include the installation of a new process control system and a new bagging station. These measures are designed to further improve the efficiency and reliability of the production process. The new systems will streamline operations and help the company meet the increasing demand for MetAMINO®.
Additionally, the upgrades will contribute to environmental sustainability by reducing emissions. The technical improvements are expected to lower nitrogen, sulfur, and CO2 emissions, aligning with Evonik’s commitment to reducing its ecological footprint. Hoehler emphasized the company’s strong motivation to meet and exceed the strictest European sustainability requirements, saying, “To reduce our ecological footprint is an ongoing, strong motivation for us.”
Expanding Global Production Capacity
Evonik is a global leader in the production of methionine, a critical component in animal feed. The company operates three world-scale methionine production hubs located in Antwerp/Wesseling (Europe), Mobile (Alabama, USA), and Singapore. Over the past three years, Evonik has invested more than €200 million in expanding its methionine production facilities, including projects in Singapore and the backward integration of methionine production in Mobile, Alabama.
These strategic investments reflect Evonik’s commitment to maintaining a robust and efficient global supply chain for MetAMINO® and supporting the growing global feed markets. The company’s ability to serve these markets from three key regions ensures it can meet the rising demand for high-quality, sustainable animal feed solutions.
MetAMINO®: Supporting Sustainable Animal Nutrition
MetAMINO® is a high-quality source of DL-methionine used in livestock production to support animal health, improve feed efficiency, and enhance sustainability. Evonik’s Animal Nutrition business line focuses on developing science-based products, services, and system solutions that help feed a growing global population with affordable, healthy, and sustainable animal protein.
Evonik’s innovative approach to animal nutrition and its ongoing investment in production capabilities reflect its commitment to addressing the world’s growing demand for healthy, affordable food. As part of its mission, Evonik continues to enhance the sustainability of its operations and reduce the environmental impact of its production processes.
Conclusion: A Strong Future for Methionine Production
The technical upgrades at Evonik’s European methionine Verbund in Antwerp and Wesseling represent a significant step forward in the company’s efforts to enhance process efficiency, reliability, and sustainability. With a focus on improving production capabilities and reducing emissions, these investments will strengthen Evonik’s position as a leading global supplier of MetAMINO®.
As the company continues to expand its global production network and improve its sustainability practices, it remains dedicated to ensuring a secure, reliable supply of high-quality methionine to meet the needs of the growing animal nutrition market.
About Evonik
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.2 billion and an operating profit (adjusted EBITDA) of €2,1 billion in 2024. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.76 billion in 2024 with more than 5,500 employees.
